Prestige Consumer Healthcare (PBH) reported quarterly EPS of $0.98, beating the Zacks Consensus Estimate of $0.89 by $0.09 (~10%). EPS also rose from $0.95 a year ago. The earnings beat is a modest positive catalyst likely to move the stock in the near term.
Prestige Consumer Healthcare (PBH) reported quarterly EPS of $0.98, beating the Zacks Consensus Estimate of $0.89 by $0.09 (~10%). EPS also rose from $0.95 a year ago. The earnings beat is a modest positive catalyst likely to move the stock in the near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
